HomeCompareSTTX vs JNJ

STTX vs JNJ: Dividend Comparison 2026

STTX yields 86956.52% · JNJ yields 2.14%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 STTX wins by $1.1970949479096829e+26M in total portfolio value
10 years
STTX
STTX
● Live price
86956.52%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.1970949479096829e+26M
Annual income
$119,439,296,340,970,800,000,000,000,000,000.00
Full STTX calculator →
JNJ
Johnson & Johnson
● Live price
2.14%
Share price
$242.49
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.5K
Annual income
$4,749.88
Full JNJ calculator →

Portfolio growth — STTX vs JNJ

📍 STTX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSTTXJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, STTX + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
STTX pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

STTX
Annual income on $10K today (after 15% tax)
$7,391,304.35/yr
After 10yr DRIP, annual income (after tax)
$101,523,401,889,825,180,000,000,000,000,000.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$182.28/yr
After 10yr DRIP, annual income (after tax)
$4,037.40/yr
At 15% tax rate, STTX beats the other by $101,523,401,889,825,180,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of STTX + JNJ for your $10,000?

STTX: 50%JNJ: 50%
100% JNJ50/50100% STTX
Portfolio after 10yr
$5.985474739548414e+25M
Annual income
$59,719,648,170,485,400,000,000,000,000,000.00/yr
Blended yield
99.77%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

STTX
No analyst data
Altman Z
-407.3
Piotroski
2/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-5.7% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

STTX buys
0
JNJ buys
0
No recent congressional trades found for STTX or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSTTXJNJ
Forward yield86956.52%2.14%
Annual dividend / share$2.00$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28%
Portfolio after 10y$1.1970949479096829e+26M$30.5K
Annual income after 10y$119,439,296,340,970,800,000,000,000,000,000.00$4,749.88
Total dividends collected$1.196917833388854e+26M$15.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: STTX vs JNJ ($10,000, DRIP)

YearSTTX PortfolioSTTX Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$8,706,352$8,695,652.17$10,594$274.49+$8.70MSTTX
2$7,084,774,695$7,075,458,897.94$11,294$360.69+$7084.76MSTTX
3$5,388,551,665,008$5,380,970,956,084.53$12,133$476.91+$5388551.65MSTTX
4$3,830,690,344,770,810$3,824,924,594,489,251.00$13,156$635.42+$3830690344.76MSTTX
5$2,545,329,554,201,369,000$2,541,230,715,532,464,600.00$14,432$854.61+$2545329554201.35MSTTX
6$1,580,797,236,863,780,800,000$1,578,073,734,240,785,100,000.00$16,056$1,162.76+$1580797236863780.75MSTTX
7$917,649,667,143,278,900,000,000$915,958,214,099,834,600,000,000.00$18,175$1,604.53+$917649667143278848.00MSTTX
8$497,908,922,842,937,000,000,000,000$496,927,037,699,093,600,000,000,000.00$21,009$2,252.68+$497908922842937032704.00MSTTX
9$252,521,915,885,494,500,000,000,000,000$251,989,153,338,052,600,000,000,000,000.00$24,911$3,229.73+$2.5252191588549452e+23MSTTX
10$119,709,494,790,968,300,000,000,000,000,000$119,439,296,340,970,800,000,000,000,000,000.00$30,458$4,749.88+$1.1970949479096829e+26MSTTX

STTX vs JNJ: Complete Analysis 2026

STTXStock

Stratex Oil & Gas Holdings, Inc., an independent energy company, focuses on the acquisition, exploitation, and development of crude oil in Kansas and Texas, as well as non-operated working interests in North Dakota, Montana, Utah, Colorado, and Kansas. The company is also involved in the sale of oil and gas. As of March 31, 2015, it owned an interest in 86 wells, as well as holds approximately 35,317 net leasehold acres in Sheridan, Montana; Williams, Billings, Divide, Mountrail, and Stark Counties, North Dakota; and Weld County, Colorado, Central Kansas, Central Utah and Zavala County, Texas. The company was formerly known as Poway Muffler and Brake, Inc. and changed its name to Stratex Oil & Gas Holdings, Inc. in May 2012. Stratex Oil & Gas Holdings, Inc. is based in Salt Lake City, Utah.

Full STTX Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this STTX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

STTX vs SCHDSTTX vs JEPISTTX vs OSTTX vs KOSTTX vs MAINSTTX vs ABBVSTTX vs MRKSTTX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.